TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded September 28, 1990